Latest Bisphosphonate Stories
Discrepancy increases risk for future bone breaks, related complications ROSEMONT, Ill., Nov.
MOSCOW, October 28, 2014 /PRNewswire/ -- Osteros Biomedica Ltd., a joint venture company of Maxwell Biotech Group and MBC Pharma Inc., and formed with the participation
ROSEMONT, Ill., June 18, 2014 /PRNewswire-USNewswire/ -- A new position paper on Medication Related Osteonecrosis of the Jaw (MRONJ) released by the American Association of Oral and Maxillofacial Surgeons,
--Recently Revised Label for Marketed Calcitonin Products Has Helped Clarify the Regulatory Landscape in the U.S.-- PHILADELPHIA, May 29, 2014 /PRNewswire/ -- Tarsa Therapeutics,
-Files patents on markers- TEL AVIV, Israel, May 27, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd.
PISA, Italy and HONG KONG, May 26, 2014 /PRNewswire/ -- Abiogen Pharma S.p.A.
A new report launched today by the International Osteoporosis Foundation (IOF) shows that osteoporosis is a serious problem throughout the Asia Pacific, with the number of fracture sufferers to rise dramatically in the coming decades.
Bisphosphonates are a group of compounds that have become well-known and are extensively used as drugs for treating bone-related diseases, such as osteoporosis.
- To swell, as grain or wood with water.